| Loss of PTEN promotes resistance to T cell–mediated immunotherapy W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... Cancer discovery 6 (2), 202-216, 2016 | 1497 | 2016 |
| Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016 | 1005 | 2016 |
| Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov … PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... J Thorac Oncol 11, S237-8, 2016 | 1005* | 2016 |
| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance W Roh, PL Chen, A Reuben, CN Spencer, PA Prieto, JP Miller, ... Science translational medicine 9 (379), eaah3560, 2017 | 823 | 2017 |
| Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia R Pan, LJ Hogdal, JM Benito, D Bucci, L Han, G Borthakur, J Cortes, ... Cancer discovery 4 (3), 362-375, 2014 | 765 | 2014 |
| Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy T Cascone, JA McKenzie, RM Mbofung, S Punt, Z Wang, C Xu, ... Cell metabolism 27 (5), 977-987. e4, 2018 | 543 | 2018 |
| AK-fold averaging cross-validation procedure Y Jung, J Hu Journal of Nonparametric Statistics 27 (2), 167-179, 2015 | 435 | 2015 |
| microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival S Rossi, M Shimizu, E Barbarotto, MS Nicoloso, F Dimitri, D Sampath, ... Blood 116 (6), 945-952, 2010 | 312 | 2010 |
| Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6 (2): 202–16. doi: 10.1158/2159-8290 W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... CD-15-0283.[PMC free article][PubMed][Cross Ref], 0 | 271* | |
| Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia A Ferrajoli, TD Shanafelt, C Ivan, M Shimizu, KG Rabe, N Nouraee, ... Blood 122 (11), 1891-1899, 2013 | 260 | 2013 |
| Non-parametric quantification of protein lysate arrays J Hu, X He, KA Baggerly, KR Coombes, BTJ Hennessy, GB Mills Bioinformatics 23 (15), 1986-1994, 2007 | 245 | 2007 |
| The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales J Hu, KR Coombes, JS Morris, KA Baggerly Briefings in Functional Genomics 3 (4), 322-331, 2005 | 219 | 2005 |
| Wild bootstrap for quantile regression X Feng, X He, J Hu Biometrika 98 (4), 995-999, 2011 | 218 | 2011 |
| Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis X Leng, T Ding, H Lin, Y Wang, L Hu, J Hu, B Feig, W Zhang, L Pusztai, ... Cancer research 69 (22), 8579-8584, 2009 | 216 | 2009 |
| Serum proteomics profiling—a young technology begins to mature KR Coombes, JS Morris, J Hu, SR Edmonson, KA Baggerly Nature biotechnology 23 (3), 291, 2005 | 216 | 2005 |
| Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database J Wang, B Wei, CT Albarracin, J Hu, SC Abraham, Y Wu BMC cancer 14 (1), 147, 2014 | 193 | 2014 |
| Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel … M Niedermeier, BT Hennessy, ZA Knight, M Henneberg, J Hu, AV Kurtova, ... Blood 113 (22), 5549-5557, 2009 | 187 | 2009 |
| Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis G Chamilos, RE Lewis, J Hu, L Xiao, T Zal, M Gilliet, G Halder, ... Proceedings of the National Academy of Sciences 105 (27), 9367-9372, 2008 | 163 | 2008 |
| Sparse logistic principal components analysis for binary data S Lee, JZ Huang, J Hu The annals of applied statistics 4 (3), 1579, 2010 | 153 | 2010 |
| Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma A Reuben, CN Spencer, PA Prieto, V Gopalakrishnan, SM Reddy, ... NPJ genomic medicine 2 (1), 10, 2017 | 144 | 2017 |
